Grifols, S.A. (FRA:OZTA)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Biopharma	6.14B	5.56B	5.01B	3.81B	4.24B
Biopharma Growth	10.51%	11.05%	31.20%	-10.08%	6.24%
Diagnostic	644.90M	670.27M	671.29M	779.11M	775.89M
Diagnostic Growth	-3.79%	-0.15%	-13.84%	0.41%	5.76%
Bio Supplies	215.66M	159.96M	146.08M	115.81M	133.22M
Bio Supplies Growth	34.83%	9.50%	26.13%	-13.07%	-50.02%
Others	209.23M	203.45M	250.17M	266.46M	222.52M
Others Growth	2.84%	-18.67%	-6.12%	19.75%	875.11%
Intersegments	-	-	-8.95M	-43.25M	-34.10M
Total	7.21B	6.59B	6.06B	4.93B	5.34B
Total Growth	9.41%	8.71%	22.92%	-7.62%	4.73%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
United States + Canada	4.09B	3.90B	3.86B	3.15B	3.60B
United States + Canada Growth	4.82%	1.12%	22.22%	-12.37%	6.16%
Rest of the World	1.58B	1.44B	1.18B	872.12M	905.80M
Rest of the World Growth	10.22%	22.19%	34.86%	-3.72%	6.41%
Spain	423.08M	362.88M	320.63M	362.41M	339.17M
Spain Growth	16.59%	13.18%	-11.53%	6.85%	26.42%
Rest of European Union	1.12B	893.05M	711.58M	544.04M	495.32M
Rest of European Union Growth	25.22%	25.50%	30.79%	9.84%	-15.82%
Total	7.21B	6.59B	6.06B	4.93B	5.34B
Total Growth	9.41%	8.71%	22.92%	-7.62%	4.73%

Source: S&P Global Market Intelligence.